Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Global Health Ltd.
Swot
Global Health Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Global Health Ltd. has 24 Strengths, 4 Weaknesses, 8 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(24)
Weakness
(4)
Opportunity
(8)
Threats
(1)
Others
(3)
Positive Breakout First Resistance ( LTP > R1)
Price crossing above SMA20 today, and greater than SMA5
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Strong Momentum: Price above short, medium and long term moving averages
Consistent Highest Return Stocks over Five Years - Nifty500
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Relative Outperformance versus Industry over 1 Week
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Company with Low Debt
Increasing profits every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Company with Zero Promoter Pledge
RSI indicating price strength
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Promoter decreasing their shareholding
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Broker price or reco upgrades in last month
Brokers upgraded recommendation or target price in the past three months
Mutual Funds Increased Shareholding in Past Month
Broker Upgrades: Stocks where brokers upgraded recommendation or price target in the past one month
FII / FPI or Institutions increasing their shareholding
Broker price or reco upgrades in last month
Mutual Funds Increased Shareholding over the Past Two Months
Mf buying for 2 months
MFs decreased their shareholding last quarter
Expensive Performers (DVM)
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks